Table 2. Sleep parameters with actigraphy in patients who completed study.
| Ashwagandha (n = 39) | Placebo (n = 19) | ANOVA | ||||
| Mean (SD) | 95% C.I. | Mean (SD) | 95% C.I. | F | Sig. | |
| Sleep onset latency (min) | ||||||
| Baseline | 41.62 (6.84) | 39.40 - 43.83 | 41.95 (6.99) | 38.58 - 45.32 | 0.030 | 0.864 |
| 5 weeks | 35.18 (7.04) | 32.90 - 37.46 | 38.11 (7.01) | 34.73 - 41.48 | 2.215 | 0.142 |
| 10 weeks | 29.00 (7.15) | 26.68 - 31.32 | 33.95 (7.66) | 30.26 - 37.64 | 5.847 | 0.019 |
| Total sleep time (min) | ||||||
| Baseline | 261.77 (34.78) | 250.49 - 273.04 | 263.00 (42.72) | 242.41 - 283.59 | 0.014 | 0.907 |
| 5 weeks | 290.92 (35.61) | 279.38 - 302.47 | 276.16 (43.46) | 255.21 - 297.11 | 1.898 | 0.174 |
| 10 weeks | 311.62 (35.81) | 300.01 - 323.22 | 292.37 (42.47) | 271.90 - 312.84 | 3.265 | 0.076 |
| Wake after sleep onset (min) | ||||||
| Baseline | 42.69 (14.67) | 37.94 - 47.45 | 44.00 (12.43) | 38.01 - 49.99 | 0.112 | 0.740 |
| 5 weeks | 38.21 (14.42) | 33.53 - 42.88 | 41.84 (12.19) | 35.96 - 47.72 | 0.895 | 0.348 |
| 10 weeks | 33.05 (14.36) | 28.40 - 37.71 | 40.00 (12.27) | 34.09 - 45.91 | 3.276 | 0.076 |
| Total time in bed (min) | ||||||
| Baseline | 346.08 (44.48) | 331.66 - 360.50 | 348.95 (47.81) | 325.90 - 371.99 | 0.051 | 0.823 |
| 5 weeks | 364.31 (45.23) | 349.65 - 378.97 | 356.11 (48.21) | 332.87 - 379.34 | 0.403 | 0.528 |
| 10 weeks | 373.67 (45.04) | 359.07 - 388.27 | 366.32 (46.85) | 343.74 - 388.90 | 0.332 | 0.567 |
| Sleep efficiency | ||||||
| Baseline | 75.63 (2.70) | 74.76 - 76.51 | 75.14 (3.73) | 73.34 - 76.94 | 0.322 | 0.573 |
| 5 weeks | 79.91 (2.67) | 79.04 - 80.77 | 77.35 (3.56) | 75.64 - 79.07 | 9.356 | 0.003 |
| 10 weeks | 83.49 (2.84) | 82.57 - 84.41 | 79.68 (3.59) | 77.95 - 81.41 | 19.265 | <0.0001 |